Skip to main content

Table 1 Evidence suggesting the beneficial effects of MSCs on the AKI-CKD transition

From: Current understanding of the administration of mesenchymal stem cells in acute kidney injury to chronic kidney disease transition: a review with a focus on preclinical models

References

Year

Animal

Model

Renal outcomes

Zhu et al. [84]

2017

Mice

Unilateral I/R injury

↓Fibrosis; ↑kidney weight and size; ↓α-SMA and collagen-I; ↓TGF-β1/Smad3

Masoud et al. [85]

2012

Rats

Unilateral I/R injury

↓Fibrosis

Semedo et al. [86]

2010

Mice

Unilateral I/R injury

↓Fibrosis; ↓proteinuria; ↑renal areas; ↓a-SMA, vimentin, and FSP-1

Gatti et al. [88]

2011

Rats

Unilateral I/R injury with contralateral nephrectomy

↑Renal function; ↓fibrosis; ↓proteinuria

Du et al. [90]

2012

Rats

Unilateral I/R injury with contralateral nephrectomy

↑Renal function; ↓fibrosis

Zou et al. [89]

2014

Rats

Unilateral I/R injury with contralateral nephrectomy

↑Renal function; ↓fibrosis; ↓α-SMA

Alfarano et al. [91]

2012

Rats

Unilateral I/R injury with contralateral nephrectomy

↑Renal function; ↓fibrosis and tubular dilation; ↓α-SMA and MMP2

Zhou et al. [93]

2016

Rats

Unilateral I/R injury with contralateral nephrectomy

↑Renal function; ↓fibrosis; ↓α-SMA; ↓microvascular rarefaction

Tögel et al. [94]

2009

Rats

Bilateral I/R injury

↑Renal function; ↓fibrosis; ↓PAI-1 and TGF-β

Du et al. [96]

2013

Rats

Bilateral I/R injury

↓Fibrosis

Rodrigues et al. [97]

2017

Rats

Bilateral I/R injury

↑Renal function; ↓FENa; ↓urinary concentrating defect; ↓renal damage score; ↓senescence

  1. I/R ischemia/reperfusion, α-SMA α-smooth muscle actin, MMP2 matrix metalloproteinase 2, FSP-1 fibroblast specific protein-1, PAI-1 plasminogen activator inhibitor-1